UK markets closed

Hikma Pharmaceuticals PLC (HIK.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
1,799.00+10.00 (+0.56%)
At close: 04:35PM BST
Show:
Income statement
Balance sheet
Annual

Cash flow

Currency in USD. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
190,000
190,000
188,000
421,000
431,000
Depreciation & amortisation
259,000
259,000
372,000
144,000
91,000
Stock-based compensation
25,000
25,000
22,000
29,000
27,000
Change in working capital
80,000
80,000
-131,000
-28,000
-208,000
Inventory
-115,000
-115,000
-102,000
38,000
-180,000
Other working capital
404,000
404,000
305,000
409,000
240,000
Other non-cash items
88,000
88,000
78,000
39,000
22,000
Net cash provided by operating activities
608,000
608,000
530,000
638,000
464,000
Cash flows from investing activities
Investments in property, plant and equipment
-204,000
-204,000
-225,000
-229,000
-224,000
Acquisitions, net
-105,000
-105,000
-380,000
-17,000
-60,000
Purchases of investments
-27,000
-27,000
-15,000
-3,000
-5,000
Sales/maturities of investments
1,000
1,000
0
6,000
2,000
Other investing activities
-23,000
-23,000
-
3,000
-3,000
Net cash used for investing activities
-333,000
-333,000
-607,000
-238,000
-283,000
Net change in cash
-62,000
-62,000
-135,000
113,000
-117,000
Cash at beginning of period
270,000
270,000
426,000
323,000
442,000
Cash at end of period
205,000
205,000
270,000
426,000
323,000
Free cash flow
Operating cash flow
608,000
608,000
530,000
638,000
464,000
Capital expenditure
-204,000
-204,000
-225,000
-229,000
-224,000
Free cash flow
404,000
404,000
305,000
409,000
240,000